Related Experiment Video
Updated: May 7, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Treatment of hypertension in obese patients]
Sophie Comte-Perret1, Vittorio Giusti, Grégoire Wuerzner
1Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. sophie.comte@chuv.ch
Abstract:
Prevalence of obesity and hypertension has increased these last decades. Around 60 to 70% of the incidence of hypertension is related to obesity. The relationship between obesity and hypertension is now well established. The sympathetic nervous system and the renin-angiotensin-aldosterone (RAA) system are activated in obese patients, mostly by insulin, and predispose the kidney to reabsorb sodium and water. In obese patients with hypertension, it is recommended to target a blood pressure < 140/90 mmHg. Lifestyle changes (weight loss, physical activity, low-salt diets) are useful to decrease blood pressure but are difficult to maintain in the long-term. When drugs are necessary, drugs that are metabolically neutral should be used, and often need to be combined to other drug classes in order to achieve blood pressure target.
Related Concept Videos
Drug Dosing: Obese Patients
Hypertension IV: Drug Therapy and Lifestyle Modifications
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Hypertension V: Nursing Management
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Heart Failure VI: Adjunct Therapies
